Table of Contents
Overview
New York, NY – July 28, 2025 : The global Coil Transcatheter Embolization and Occlusion Devices Market is projected to grow from US$ 1.8 billion in 2024 to US$ 3.7 billion by 2034. This growth reflects a strong CAGR of 7.5% during the forecast period. North America currently leads the market with a 43% share and a value of US$ 0.7 billion. This dominance is due to advanced healthcare systems, rising adoption of minimally invasive procedures, and the presence of key market players. Increasing demand for vascular treatment solutions continues to fuel regional and global expansion.
Rising cases of vascular diseases and cancer, such as aneurysms and arteriovenous malformations, are major growth drivers. These conditions require effective and less invasive treatments. Transcatheter embolization devices offer a safer alternative to traditional surgery. They are commonly used to block blood flow in affected vessels, helping prevent serious complications. Their growing usage in managing gastrointestinal bleeding and other internal hemorrhages is expanding the market’s clinical relevance and application across multiple specialties, especially in interventional radiology.
Technological advancements have significantly improved embolization devices. The development of micro-coils with better biocompatibility and precision enhances clinical outcomes. These innovations allow for faster procedures and better recovery times. As a result, more physicians are adopting these tools in place of open surgery. Hospitals and clinics are also shifting towards outpatient treatments using these devices, which helps reduce healthcare costs and inpatient burden. This trend is likely to continue, driven by ongoing product upgrades and innovation by key manufacturers.
The market is also benefiting from increased healthcare investment in developing regions. Countries in Asia-Pacific and Latin America are expanding access to interventional radiology. Public and private sectors are improving hospital infrastructure and medical training. This supports wider use of embolization and occlusion devices in non-traditional markets. In addition, aging populations and the increasing burden of chronic diseases contribute to market growth. The combination of rising demand and government support is creating strong opportunities for manufacturers to expand their global footprint.
Despite these drivers, some challenges remain. High device costs and limited reimbursement policies may slow adoption, especially in cost-sensitive markets. Additionally, transcatheter procedures require specialized skills, which limits usage in under-resourced areas. However, leading companies are addressing these issues through training programs, partnerships, and affordable device development. Supportive clinical data and disease prevalence reports, such as the 250 million people living with unruptured aneurysms globally, underline the critical need for these devices. The market is set for sustained, innovation-driven growth over the coming decade.
Key Takeaways
- An industry expert shared that the coil transcatheter embolization market is projected to grow from USD 1.8 billion in 2024 to USD 3.7 billion by 2034.
- According to recent insights, detachable coils dominated the market in 2024, accounting for 56.3% of the total global revenue.
- It was noted that hemorrhage control applications led the segment in 2024, capturing approximately 23.6% of the global market share.
- Experts highlighted that platinum and platinum alloy coils were preferred the most in 2024, with a commanding 43.4% market share.
- The hospital sector emerged as the top end-user in 2024, contributing 56.9% of the global market revenue for these devices.
- Analysts revealed that North America remained the leading regional market in 2024, securing more than 43% of the total revenue share.
Regional Analysis
North America leads the coil transcatheter embolization and occlusion devices market, holding over 43% of the total market share. This equates to a market value of around USD 0.7 billion in 2024. The growth is driven by high healthcare spending, rising adoption of minimally invasive procedures, and technological progress. The U.S. and Canada have advanced healthcare systems and a growing number of patients with vascular conditions like aneurysms and gastrointestinal bleeding. These factors are boosting demand for modern embolization devices with better outcomes and reduced complications.
The shift from traditional surgery to interventional radiology is further fueling market growth in North America. Devices like precision-engineered micro-coils with improved safety and biocompatibility are gaining traction. Favorable reimbursement policies also support wider treatment access. The presence of key manufacturers and ongoing innovations enhance competition and product availability. Growing awareness among healthcare providers and patients about the safety and success of coil embolization procedures, along with an aging population, will continue to drive market expansion in the coming years.
Segmentation Analysis
Product Type Analysis
The coil transcatheter embolization and occlusion devices market is segmented by product type into detachable coils, pushable coils, and others. In 2024, detachable coils led the market with a 56.3% share. This dominance is due to their precision and flexibility during procedures. These coils allow physicians to control placement accurately, reducing the risk of complications. Their effectiveness in treating aneurysms, arteriovenous malformations, and gastrointestinal bleeding has boosted demand. Improvements in coil design and biocompatibility further enhance their adoption, making detachable coils a top choice in clinical settings.
Procedure Type Analysis
By procedure type, the market includes hemorrhage control, vascular occlusion, aneurysm treatment, tumor embolization, and others. Hemorrhage control accounted for the largest share at 23.6% in 2024. This segment is driven by the increasing need to manage severe bleeding, especially in trauma and surgery. Coil embolization allows rapid and targeted vessel occlusion, minimizing risks and improving recovery. Its minimally invasive nature and proven success in treating bleeding-related complications have made it a preferred technique. Technological advancements have further strengthened its role in modern medical practice.
Material Analysis
The market is categorized by material into platinum or platinum alloy, nitinol, stainless steel, and others. In 2024, platinum and platinum alloy held the top position with a 43.4% market share. These materials offer excellent mechanical strength and resist corrosion, ensuring durability inside the body. Their radiopaque nature improves visibility during procedures, enabling accurate placement. This is crucial for conditions like aneurysms and arteriovenous malformations. Platinum coils conform easily to vessel shapes, helping achieve complete occlusion. These advantages make them a preferred material among healthcare providers.
End-User Analysis
End-user segmentation includes hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research institutes. Hospitals dominated in 2024, capturing 56.9% of the market. This is because hospitals perform most interventional radiology procedures. They also employ trained specialists and have advanced imaging and surgical infrastructure. These factors ensure accurate and safe embolization procedures. The rise in demand for minimally invasive treatments further supports hospital dominance. Their ability to handle complex cases with modern tools makes them the primary setting for using coil embolization and occlusion devices.
Key Segments Analysis
By Product Type
- Detachable Coils
- Pushable Coils
- Other Product Types
By Procedure Type
- Hemorrhage Control
- Vascular Occlusion
- Aneurysm Treatment
- Tumor Embolization
- Other Procedure Types
By Material
- Platinum or Platinum Alloy
- Nickel Titanium (Nitinol)
- Stainless Steel
- Other Materials
By End-User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
- Research and Academic Institutes
Key Players Analysis
The coil transcatheter embolization and occlusion devices market is highly competitive. Key players include Boston Scientific Corporation, Terumo Corporation, Abbott Laboratories, and Medtronic. These companies hold major shares due to their innovative solutions for conditions like aneurysms, arteriovenous malformations, and gastrointestinal bleeding. They invest heavily in research and development. Their focus is on launching advanced devices such as micro-coils and bioabsorbable coils. These products aim to improve patient outcomes, reduce risks, and offer high precision during procedures. Their innovation helps maintain a strong position in the global market.
To expand their reach, these companies adopt various strategic moves. Mergers, acquisitions, and partnerships are common. These efforts help widen product portfolios and boost global distribution. For instance, collaborations with hospitals and research centers help in developing custom devices. They also assist in fast-tracking clinical approvals and gaining regulatory clearances. As competition grows, strong R&D and smart partnerships remain key to staying ahead. These strategies support steady market growth and brand recognition.
Leading Key Players in the Cell Therapy Market
- Johnson and Johnson
- Medtronic Plc
- Stryker Corporation
- Cook Medical
- Terumo Medical Corporation
- B. Braun Interventional Systems Inc.
- Abbott Laboratories.
- Boston Scientific Corporation
- Merit Medical Systems
- Pfizer, Inc.
Emerging Trends
1. Shift Toward Minimally Invasive Procedures
Healthcare providers are increasingly choosing coil embolization over traditional surgery. This method is less invasive, which means patients experience less pain and recover faster. It also lowers the risk of complications, making it a safer option. As a result, more hospitals and clinics are adopting coil embolization procedures. The rising preference for minimally invasive treatments is driving market growth. Both doctors and patients are becoming more comfortable with these procedures. This trend is expected to continue as healthcare systems focus on efficiency, better outcomes, and shorter hospital stays.
2. Advancements in Coil Technology
New coil technologies are improving treatment precision. Manufacturers are creating thinner and more flexible coils that can be placed more accurately. Some of these coils offer better control during procedures, allowing doctors to navigate delicate blood vessels with ease. Advanced materials are also being used to promote faster healing and reduce long-term risks. These innovations make the devices safer and more effective. As technology continues to evolve, newer coil designs will support more complex cases, opening doors to wider usage in various medical conditions.
3. Increased Use in Neurology
Coil embolization is seeing growing use in neurology, especially for treating brain aneurysms. Doctors now feel more confident using these devices in sensitive areas like the brain. This confidence is due to improved coil design and better imaging guidance. Neurological conditions often require high precision, and embolization coils are proving effective in reducing bleeding risks. As awareness and training increase, more neurologists are turning to these devices. The trend highlights how embolization is expanding beyond general vascular care and into highly specialized fields like brain surgery.
4. Growth of Bioabsorbable Coils
Bioabsorbable coils are gaining attention in the medical field. These are made from materials that naturally dissolve in the body over time. They eliminate the need for surgical removal and reduce the risk of long-term complications. Doctors appreciate that they can provide treatment without leaving permanent foreign objects in the body. This makes them ideal for patients with higher sensitivity or long-term health concerns. As research progresses, bioabsorbable coils are becoming more reliable. Their growing acceptance is helping to shape the next phase of embolization treatments.
5. Integration with Imaging Technologies
Coil devices are now designed to work more efficiently with real-time imaging systems. Technologies like fluoroscopy, CT, and MRI help doctors see exactly where the coil is placed. This ensures higher accuracy during procedures and improves safety for the patient. The ability to monitor placement in real time also speeds up the process. Imaging-guided coil embolization is becoming the standard in many hospitals. This integration is a major step forward in making treatments more precise, especially in complex or high-risk cases.
6. Broader Application in Cancer Treatments
Coil embolization is being used more often in cancer care. Doctors are applying it to block blood flow to tumors, especially in the liver, kidneys, and lungs. This technique is often combined with other treatments like chemotherapy to boost effectiveness. Cutting off a tumor’s blood supply can help shrink it or slow its growth. This minimally invasive method is less stressful on the body than surgery. As oncologists explore more uses, coil embolization is becoming a valuable tool in targeted cancer therapy.
7. Customized and Patient-Specific Solutions
Personalized medicine is shaping the future of embolization. Companies are developing coil devices tailored to fit each patient’s unique anatomy. These custom coils improve placement accuracy and reduce the chance of complications. They are especially useful for patients with complex vascular conditions. By adjusting the coil’s size, shape, or material, doctors can ensure better results. This approach supports safer, more effective procedures. As technology advances, we can expect to see more demand for personalized solutions in the embolization market.
Use Cases
1. Treating Brain Aneurysms
Embolization coils are often used to treat brain aneurysms. These are balloon-like bulges in blood vessels that can burst and cause a stroke. Instead of risky open brain surgery, doctors insert a thin tube through the artery. They then place soft coils into the aneurysm. This stops blood from entering the bulge. Over time, a clot forms around the coils, sealing the area. This method helps lower the risk of rupture and improves recovery. It’s a safer option for many patients and has become a standard treatment in many hospitals worldwide.
2. Controlling Internal Bleeding
Coil embolization is widely used to stop internal bleeding. It helps patients who suffer from trauma, injuries, or complications after surgery. For example, if someone is bleeding in the stomach or kidneys, doctors can use a coil to block the bleeding vessel. This avoids the need for major surgery. The coil cuts off blood flow to the injured area, allowing it to heal. It’s a fast, safe, and minimally invasive option. Doctors prefer this method when they need to act quickly, especially in emergencies or critical care settings.
3. Blocking Blood Flow to Tumors
In some cancer treatments, coils are used to block blood vessels that feed tumors. This is most common in liver cancer cases. The goal is to cut off the blood supply, which helps shrink the tumor. This technique is often used with chemotherapy. Doctors call it transarterial chemoembolization (TACE). The coil keeps the drug concentrated in the tumor and reduces damage to healthy tissue. It is less invasive than surgery and often used when surgery is not possible. This method can slow cancer growth and improve patient outcomes.
4. Treating Arteriovenous Malformations (AVMs)
Arteriovenous malformations (AVMs) are abnormal connections between arteries and veins. These can rupture and cause bleeding. Coil embolization is a safe way to treat AVMs. Doctors insert a catheter and place coils to block the abnormal vessel. This stops blood from flowing through the AVM. It’s especially helpful when surgery would be too risky. The treatment lowers the chance of bleeding and related health issues. It can be done under local anesthesia and usually requires little recovery time. Coil embolization offers a safe and effective solution for patients with AVMs.
5. Preventing Blood Flow to Damaged Organs
When an organ like the spleen is injured, surgery is not always the best solution. In such cases, doctors use coils to block blood flow only to the damaged part. This prevents further bleeding and saves the rest of the organ. For example, after an accident, the spleen might be injured but not fully ruptured. Instead of removing it, doctors place coils to stop blood flow to the injured area. This method is less invasive and helps protect overall organ function while controlling bleeding.
6. Preparing for Surgery
Before certain surgeries, doctors use coils to reduce the risk of bleeding. This is common in surgeries involving large tumors or complex areas. By blocking blood flow ahead of time, surgeons can perform the operation more safely. For instance, if a tumor is fed by large blood vessels, coils can be placed to shut them off. This lowers the amount of blood loss during surgery. It also makes the surgical field clearer and safer for the doctor. Pre-surgical embolization helps improve outcomes and reduces complications during the procedure.
Conclusion
In conclusion, the coil transcatheter embolization and occlusion devices market is set for steady growth, driven by rising cases of vascular diseases and a growing shift toward minimally invasive treatments. Advancements in coil technology and expanding applications in neurology and cancer care are supporting wider adoption. Emerging economies are also contributing to market growth as access to modern healthcare improves. While challenges like high costs and skill requirements remain, ongoing innovation and strategic collaborations are helping overcome these barriers. As hospitals and clinics focus on improving patient outcomes with safer, faster procedures, the demand for advanced embolization solutions is expected to increase steadily over the next decade.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
